MyoTherix Overview

  • Founded
  • 2013

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

MyoTherix General Information


Developer of innovative therapeutics intended to be used for the treatment of muscle disorders. The company utilizes an innovative and novel approach to target both cardiac and skeletal muscle weakness, enabling patients to avail disease-modifying drugs and therapies and stay fit and healthy.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Primary Office
  • 2600 10Th Street
  • Suite 435
  • Berkeley, CA 94710-3105
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MyoTherix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 22-Sep-2021 00.00 Completed Out of Business
2. Early Stage VC (Series B1) 27-Feb-2017 00.000 00.00 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 08-Jul-2015 $1M $1M 000 Completed Generating Revenue
To view MyoTherix’s complete valuation and funding history, request access »

MyoTherix Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-2 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B-1 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A 1,000,000 $0.001000 5% $1 $1 1x $1 11.2%
To view MyoTherix’s complete cap table history, request access »

MyoTherix Patents

MyoTherix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160207893-A1 Novel calcium modulators Abandoned 30-Dec-2014 0000000000
JP-2018500382-A New calcium regulator Pending 30-Dec-2014 0000000000
EP-3240547-A4 Novel calcium modulators Withdrawn 30-Dec-2014 0000000000
EP-3240547-A1 Novel calcium modulators Withdrawn 30-Dec-2014 0000000000
CA-2971869-A1 Novel calcium modulators Abandoned 30-Dec-2014 C07D281/10
To view MyoTherix’s complete patent history, request access »